State Street’s Integra LifeSciences IART Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $52.9M | Buy |
2,946,862
+60,306
| +2% | +$843K | ﹤0.01% | 1810 |
|
|
2026
Q1 | $27.2M | Buy |
2,886,556
+73,941
| +3% | +$812K | ﹤0.01% | 2072 |
|
|
2025
Q4 | $34.9M | Buy |
2,812,615
+21,717
| +0.8% | +$289K | ﹤0.01% | 1950 |
|
|
2025
Q3 | $40M | Sell |
2,790,898
-35,567
| -1% | -$487K | ﹤0.01% | 1844 |
|
|
2025
Q2 | $34.7M | Buy |
2,826,465
+79,033
| +3% | +$1.15M | ﹤0.01% | 1874 |
|
|
2025
Q1 | $60.4M | Sell |
2,747,432
-105,485
| -4% | -$2.48M | ﹤0.01% | 1548 |
|
|
2024
Q4 | $64.7M | Buy |
2,852,917
+26,662
| +0.9% | +$582K | ﹤0.01% | 1590 |
|
|
2024
Q3 | $51.4M | Buy |
2,826,255
+46,892
| +2% | +$1.09M | ﹤0.01% | 1698 |
|
|
2024
Q2 | $81M | Buy |
2,779,363
+661,026
| +31% | +$19.6M | ﹤0.01% | 1399 |
|
|
2024
Q1 | $75.1M | Buy |
2,118,337
+2,570
| +0.1% | +$103K | ﹤0.01% | 1491 |
|
|
2023
Q4 | $92.1M | Sell |
2,115,767
-21,794
| -1% | -$858K | ﹤0.01% | 1339 |
|
|
2023
Q3 | $81.6M | Sell |
2,137,561
-80,044
| -4% | -$3.37M | ﹤0.01% | 1314 |
|
|
2023
Q2 | $91.2M | Buy |
2,217,605
+50,621
| +2% | +$2.44M | ﹤0.01% | 1283 |
|
|
2023
Q1 | $124M | Buy |
2,166,984
+63,048
| +3% | +$3.55M | 0.01% | 1046 |
|
|
2022
Q4 | $118M | Buy |
2,103,936
+61,296
| +3% | +$3.12M | 0.01% | 1069 |
|
|
2022
Q3 | $86.5M | Buy |
2,042,640
+67,534
| +3% | +$3.46M | 0.01% | 1207 |
|
|
2022
Q2 | $107M | Sell |
1,975,106
-30,021
| -1% | -$1.8M | 0.01% | 1101 |
|
|
2022
Q1 | $129M | Buy |
2,005,127
+46,038
| +2% | +$3.03M | 0.01% | 1116 |
|
|
2021
Q4 | $131M | Buy |
1,959,089
+33,341
| +2% | +$2.26M | 0.01% | 1100 |
|
|
2021
Q3 | $132M | Buy |
1,925,748
+23,864
| +1% | +$1.69M | 0.01% | 1063 |
|
|
2021
Q2 | $130M | Buy |
1,901,884
+160,375
| +9% | +$11.3M | 0.01% | 1103 |
|
|
2021
Q1 | $120M | Sell |
1,741,509
-9,248
| -0.5% | -$627K | 0.01% | 1094 |
|
|
2020
Q4 | $114M | Sell |
1,750,757
-23,433
| -1% | -$1.26M | 0.01% | 1046 |
|
|
2020
Q3 | $83.8M | Sell |
1,774,190
-41,229
| -2% | -$1.96M | 0.01% | 1092 |
|
|
2020
Q2 | $85.3M | Buy |
1,815,419
+6,072
| +0.3% | +$298K | 0.01% | 1079 |
|
|
2020
Q1 | $80.8M | Sell |
1,809,347
-2,582
| -0.1% | -$135K | 0.01% | 958 |
|
|
2019
Q4 | $106M | Sell |
1,811,929
-27,382
| -1% | -$1.63M | 0.01% | 1012 |
|
|
2019
Q3 | $110M | Sell |
1,839,311
-242,914
| -12% | -$14.5M | 0.01% | 947 |
|
|
2019
Q2 | $116M | Buy |
2,082,225
+18,105
| +0.9% | +$932K | 0.01% | 934 |
|
|
2019
Q1 | $115M | Buy |
2,064,120
+63,108
| +3% | +$3.21M | 0.01% | 930 |
|
|
2018
Q4 | $90.2M | Sell |
2,001,012
-190,836
| -9% | -$10.5M | 0.01% | 960 |
|
|
2018
Q3 | $144M | Buy |
2,191,848
+152,857
| +7% | +$9.5M | 0.01% | 855 |
|
|
2018
Q2 | $131M | Buy |
2,038,991
+366,183
| +22% | +$22.7M | 0.01% | 871 |
|
|
2018
Q1 | $92.6M | Sell |
1,672,808
-276,174
| -14% | -$14.5M | 0.01% | 1056 |
|
|
2017
Q4 | $93.3M | Buy |
1,948,982
+364,136
| +23% | +$17.8M | 0.01% | 1049 |
|
|
2017
Q3 | $80M | Buy |
1,584,846
+9,721
| +0.6% | +$499K | 0.01% | 1109 |
|
|
2017
Q2 | $85.9M | Buy |
1,575,125
+78,082
| +5% | +$3.73M | 0.01% | 1037 |
|
|
2017
Q1 | $63.1M | Buy |
1,497,043
+113,809
| +8% | +$4.86M | 0.01% | 1189 |
|
|
2016
Q4 | $59.3M | Buy |
1,383,234
+81,090
| +6% | +$3.3M | 0.01% | 1171 |
|
|
2016
Q3 | $53.7M | Buy |
1,302,144
+99,734
| +8% | +$4.18M | 0.01% | 1188 |
|
|
2016
Q2 | $48M | Buy |
1,202,410
+54,066
| +5% | +$1.95M | 0.01% | 1205 |
|
|
2016
Q1 | $38.7M | Buy |
1,148,344
+31,960
| +3% | +$996K | ﹤0.01% | 1293 |
|
|
2015
Q4 | $37.8M | Buy |
1,116,384
+33,110
| +3% | +$1.03M | ﹤0.01% | 1312 |
|
|
2015
Q3 | $32.3M | Sell |
1,083,274
-124,652
| -10% | -$3.9M | ﹤0.01% | 1422 |
|
|
2015
Q2 | $33.3M | Buy |
1,207,926
+22,963
| +2% | +$612K | ﹤0.01% | 1521 |
|
|
2015
Q1 | $29.9M | Buy |
1,184,963
+44,914
| +4% | +$1.06M | ﹤0.01% | 1554 |
|
|
2014
Q4 | $25.3M | Buy |
1,140,049
+27,655
| +2% | +$561K | ﹤0.01% | 1636 |
|
|
2014
Q3 | $22.6M | Sell |
1,112,394
-2,627
| -0.2% | -$52.3K | ﹤0.01% | 1654 |
|
|
2014
Q2 | $21.4M | Sell |
1,115,021
-29,529
| -3% | -$550K | ﹤0.01% | 1774 |
|
|
2014
Q1 | $21.5M | Buy |
1,144,550
+104,320
| +10% | +$2.01M | ﹤0.01% | 1735 |
|
|
2013
Q4 | $20.3M | Buy |
1,040,230
+19,887
| +2% | +$365K | ﹤0.01% | 1738 |
|
|
2013
Q3 | $16.8M | Buy |
1,020,343
+12,573
| +1% | +$202K | ﹤0.01% | 1809 |
|
|
2013
Q2 | $15.1M | Buy |
+1,007,770
| New | +$14.8M | ﹤0.01% | 1807 |
|
Other funds holding IART
RCMNY
PCMI
State Street's IART Position: Q2 2026 in Review
State Street increased its Integra LifeSciences (IART) stake by 2.1% in Q2 2026, buying an estimated $843K and bringing the position to 2,946,862 shares worth $52.9M. The position accounts for ﹤0.01% of the portfolio, ranked #1810.
State Street first reported a position in IART in Q2 2013 and has held it in 53 quarters since. The position peaked at $144M in Q3 2018. 212 funds tracked by Wall St. Rank hold IART as of Q2 2026.
- State Street held 2,946,862 shares of Integra LifeSciences worth $52.9M as of Q2 2026.
- State Street bought 60,306 Integra LifeSciences shares in Q2 2026, an estimated $843K.
- Integra LifeSciences made up ﹤0.01% of State Street's portfolio in Q2 2026, its #1810 holding.
- State Street first reported a position in Integra LifeSciences in Q2 2013 and has held it in 53 quarters since.
- State Street's Integra LifeSciences position peaked at $144M in Q3 2018.
- 212 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2026.
Based on State Street's 13F filing for Q2 2026, filed 7 Aug 2026.